76 related articles for article (PubMed ID: 7291876)
1. [Electrophysiological variations induced by (-) eburnamonine in patients with chronic cerebrovascular insufficiency].
Facciolla D; Mozzillo A; Rossi A; Ruocco A; Serra C
Riv Neurol; 1980; 50(6):383-405. PubMed ID: 7291876
[TBL] [Abstract][Full Text] [Related]
2. [Our experience with rheoencephalography. Qualitative REG study of 1000 cases of verified chronic cerebrovascular insufficiency].
Facciolla D; Mozzillo A; Nolfe G; Portoghese R; Rossi A; Ruocco A; Serra C
Riv Neurol; 1980; 50(6):363-82. PubMed ID: 7291875
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and electrophysiologic changes produced by (--) eburnamonine in acute and post-acute stages of head injuries].
Facciolla D; Ruocco A; Rossi A; Serra C; Bufalino L; Cavrini P
Riv Neurol; 1983; 53(1):15-33. PubMed ID: 6857109
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and experimental evaluation of the use of eburnamonine in acute anc chronic cerebro-vascular insufficiency].
Rampello L; Barbagallo G; Costanzo E; Sciacca A; Russo S
Clin Ter; 1981 Feb; 96(4):371-81. PubMed ID: 7214860
[No Abstract] [Full Text] [Related]
5. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
De Pergola E; Di Lorenzo L; De Pergola G
G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
[No Abstract] [Full Text] [Related]
6. Pharmaco-EEG study on vincamine and on teproside in patients with chronic cerebrovascular disease.
Martucci N; Manna V; Agnoli A
Int J Clin Pharmacol Res; 1984; 4(4):291-302. PubMed ID: 6500776
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of (-)eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia.
Marolda M; Fragassi N; Buscaino GA
Eur Neurol; 1978; 17 Suppl 1():159-66. PubMed ID: 381006
[TBL] [Abstract][Full Text] [Related]
8. [Study of the antihypoxic effect of eburnamonine in acute and recurrent anoxia on the cerebral electric activity in curarized rats. Comparison with vincamine].
Van Den Driessche J; Linée P; Lacroix P; Le Pollès JB
C R Seances Soc Biol Fil; 1977; 171(5):1081-7. PubMed ID: 146550
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
Linquette M
Lille Med; 1978 May; 23(5 Suppl 1):379-81. PubMed ID: 682847
[No Abstract] [Full Text] [Related]
10. CBF changes after (-)eburnamonine infusion in patients with cerebrovascular insufficiency.
Gossetti B; Ventura M; Damiano M; Bait C; Zaccaria A
Eur Neurol; 1978; 17 Suppl 1():171-2. PubMed ID: 753632
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of combined somatosensory evoked potential, motor evoked potential, and electroencephalography monitoring during carotid endarterectomy.
Alcantara SD; Wuamett JC; Lantis JC; Ulkatan S; Bamberger P; Mendes D; Benvenisty A; Todd G
Ann Vasc Surg; 2014 Apr; 28(3):665-72. PubMed ID: 24495327
[TBL] [Abstract][Full Text] [Related]
12. Electroencephalography (EEG) and somatosensory evoked potentials (SEP) to prevent cerebral ischaemia in the operating room.
Florence G; Guerit JM; Gueguen B
Neurophysiol Clin; 2004 Feb; 34(1):17-32. PubMed ID: 15030797
[TBL] [Abstract][Full Text] [Related]
13. Experimental clinical studies on the effect of eburnamonine in cerebrovascular disorders.
Jansen W; O'Connolly M; Lehmann E; Mayer M
Pharmacopsychiatry; 1986 Sep; 19(5):389-94. PubMed ID: 3534902
[TBL] [Abstract][Full Text] [Related]
14. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
Mikus P
Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
[TBL] [Abstract][Full Text] [Related]
15. [Ketamine racemate versus S-(+)-ketamine with or without antagonism with physostigmine. A quantitative EEG study on volunteers].
Engelhardt W; Stahl K; Marouche A; Hartung E; Dierks T
Anaesthesist; 1994 Nov; 43 Suppl 2():S76-82. PubMed ID: 7840418
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO"].
Chukanova EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):49-52. PubMed ID: 21311488
[TBL] [Abstract][Full Text] [Related]
17. Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency.
Hadjiev D; Yancheva S
Arzneimittelforschung; 1976; 26(10a):1947-50. PubMed ID: 1037222
[TBL] [Abstract][Full Text] [Related]
18. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
Lanfranchi M; Magnani G; Sinforiani E; Casali R
Int J Clin Pharmacol Res; 1984; 4(4):307-12. PubMed ID: 6389380
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostics and treatment tactics for chronic cerebrovascular disorders with the use of single photon emission computed tomography].
Murashko NK
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):51-5. PubMed ID: 18427520
[TBL] [Abstract][Full Text] [Related]
20. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
Franzini C; Ferrante P
Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
